Lisa Ewbank - Synopsys Vice President - Investor Relations
SNPS Stock | USD 628.50 7.52 1.18% |
President
Lisa Ewbank is Vice President - Investor Relations of Synopsys
Phone | 650-584-5000 |
Web | https://www.synopsys.com |
Synopsys Management Efficiency
The company has return on total asset (ROA) of 0.0467 % which means that it generated a profit of $0.0467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1555 %, meaning that it created $0.1555 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Sagnik Nandy | Okta Inc | N/A | |
Kerry McLean | Intuit Inc | 60 | |
CHINCHI TENG | Cadence Design Systems | 59 | |
Laura Fennell | Intuit Inc | 64 | |
Marianna Tessel | Intuit Inc | 57 | |
John Maddison | Fortinet | N/A | |
Brian Lorig | KLA Tencor | 51 | |
Stephen Hope | Autodesk | 58 | |
Eric Kelleher | Okta Inc | 53 | |
George Kurtz | Crowdstrike Holdings | 54 | |
Michael Xie | Fortinet | 56 | |
Patrice Perche | Fortinet | 62 | |
Andrew Anagnost | Autodesk | 60 | |
John Wall | Cadence Design Systems | 54 | |
Michelle Clatterbuck | Intuit Inc | 56 |
Management Performance
Return On Equity | 0.16 | ||||
Return On Asset | 0.0467 |
Synopsys Leadership Team
Elected by the shareholders, the Synopsys' board of directors comprises two types of representatives: Synopsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synopsys. The board's role is to monitor Synopsys' management team and ensure that shareholders' interests are well served. Synopsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synopsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sassine Ghazi, President CEO | ||
Shankar Krishnamoorthy, Head Development | ||
Shelagh Glaser, Chief Officer | ||
Charlie Matar, Senior Group | ||
John Runkel, General Counsel and Corporate Secretary | ||
Sudhindra Kankanwadi, Principal Accounting Officer, Vice President Corporate Controller | ||
Deirdre Hanford, Chief Officer | ||
Antonio Varas, Chief Officer | ||
Michael Sanie, VP Communication | ||
Ann Minooka, Chief Officer | ||
Alessandra Costa, Senior Operations | ||
Janet Collinson, HR Officer | ||
Jason Schmitt, General Group | ||
Raja Tabet, Senior Group | ||
Janet Lee, General Secretary | ||
Paul Stravers, Principal Engineer | ||
John Koeter, Senior Strategy | ||
Joseph Logan, Executive VP of Sales and Corporate Marketing | ||
Trac Pham, Chief Officer | ||
Erika McEnroe, Senior Counsel | ||
Aart Geus, Co-Founder, Chairman and Co-CEO | ||
Lisa Ewbank, Vice President - Investor Relations | ||
Richard Mahoney, Chief Officer | ||
Sriram Sitaraman, Senior Officer | ||
Jill Larsen, Chief Officer |
Synopsys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synopsys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.16 | ||||
Return On Asset | 0.0467 | ||||
Profit Margin | 0.35 % | ||||
Operating Margin | 0.23 % | ||||
Current Valuation | 110.96 B | ||||
Shares Outstanding | 185.04 M | ||||
Shares Owned By Insiders | 0.41 % | ||||
Shares Owned By Institutions | 78.40 % | ||||
Number Of Shares Shorted | 6.54 M | ||||
Price To Earning | 50.25 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.